Drugs in Dev.
Trauma (Emergency, Injury, Surgery)
Phase III
Australia 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bromelain
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase III
Sponsor : MediWound
Deal Size : Undisclosed
Deal Type : Agreement
Details : The agreement is part of MediWound's global commercialization strategy that will expand the medical and commercial potential of NexoBrid to treat skin burns.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Undisclosed
January 02, 2020
Lead Product(s) : Bromelain
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase III
Sponsor : MediWound
Deal Size : Undisclosed
Deal Type : Agreement
